GS030

N/A

Report date: 2023/10/26 17:12:03

Base Information

Drug NameGS030
Drug Alias NameAAV2 7m8AAV2.7m8-ChrimsonR-tdTomatoGS030-MDGS-030GS030 DP
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2.7m8 vector
Mechanisms of ActionGene transference
TargetsChrimsonR
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGensight Biologics
China Registration ClassN/A

Develop Information

Active CompaniesGensight Biologics
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A